Accelerator

Inveready

Founded 2008. Active early-stage investor across ICT, biotech, and fintech with multiple fund vehicles.

SpainBarcelonaSeed to GrowthSoftwareBiotechFintech

Details

Location

Barcelona, Spain

Category

Accelerator

Stage

Seed to Growth

Profile

/spain/accelerator/inveready

Similar entries

Matched by sector and location overlap

Mambu

Berlin, Germany · Startup

Composable banking platform letting digital lenders and neobanks launch services quickly.

StartupGrowthFintechSoftware

Ageras

Copenhagen, Denmark · Startup

Ageras provides a platform for small businesses that combines banking, accounting, payroll, invoicing, and tax tools in one place.

StartupGrowthFintechAccountingSMB SaaS

AgeVolt

Bratislava, Slovakia · Startup

AgeVolt offers a digital ecosystem for EV charging that integrates with building energy management to prevent overloads and blackouts. Its platform optimizes charging schedules, manages access, and supports payments across fleets and commercial properties. The company is building a network model described as a “booking.com for private chargers,” unlocking underused charging infrastructure. By 2026, AgeVolt is a notable Slovak player in smart charging.

StartupGrowthEV ChargingEnergySoftware

Alan

Paris, France · Startup

Modern health insurance platform streamlining getting care for European employees.

StartupGrowthHealthSoftware

AltFins

Bratislava, Slovakia · Startup

AltFins is a cloud-based platform for crypto traders to screen, analyze, and trade across multiple exchanges. It provides advanced charting, signals, and portfolio tools used by professional and institutional users. By 2026, AltFins has carved out a niche as a serious trading platform in the crypto analytics market.

StartupGrowthFintechCryptoAnalytics

Azafaros

Leiden, Netherlands · Startup

Azafaros is a clinical-stage biotech company developing oral therapies for rare genetic metabolic disorders, including lysosomal diseases. Its lead development strategy focuses on compounds designed to cross the blood-brain barrier and address severe neurological progression in underserved pediatric conditions.

StartupGrowthBiotechLife SciencesPharma

Comments

New comments are moderated before publishing

Loading comments...

Checking login status...